seed
Stage
1
Investors
About
Immunethep develops preventive and therapeutic multivalent immunotherapies, including vaccines and monoclonal antibodies, to enhance the immune response against bacterial infections and address antimicrobial resistance.
Explore Immunethep's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.